elacestrant hydrochloride
Term · Oncology and biomedicine · MLC-T-ONC-013293
The hydrochloride salt form of elacestrant, an orally available, selective estrogen receptor degrader (SERD), with antineoplastic activity. Upon oral administration, elacestrant acts as a SERD, which binds to the estrogen receptor (ER) and induces a conformational change that results in the proteosomal degradation of the receptor. This prevents ER-mediated signaling and inhibits proliferation of ER-expressing cancer cells.
| Identifier | MLC-T-ONC-013293 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | RAD-1901 dihydrochloride; RAD1901 dihydrochloride |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013293",
"term": "elacestrant hydrochloride",
"field": "Oncology and biomedicine",
"definition": "The hydrochloride salt form of elacestrant, an orally available, selective estrogen receptor degrader (SERD), with antineoplastic activity. Upon oral administration, elacestrant acts as a SERD, which binds to the estrogen receptor (ER) and induces a conformational change that results in the proteosomal degradation of the receptor. This prevents ER-mediated signaling and inhibits proliferation of ER-expressing cancer cells.",
"synonyms": [
"RAD-1901 dihydrochloride",
"RAD1901 dihydrochloride"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/elacestrant-hydrochloride/"
}
Record 6,497 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.